Our Mission
To create a cure for metastatic cancer through use of novel molecular radionuclide technology.
Metastatic cancer remains one of the most dire and feared diseases, causing the deaths of up to 600,000 Americans per year. Metastatic cancer exhibits the features of a Darwinian evolution system, constantly changing via new genetic mutations to circumvent most chemotherapeutic regimens. Only radiation offers the potential to overcome the inherent mutability of cancer cells.
Traditional radiotherapy often causes severe side effects and is of little use for disseminated metastatic cancer. Oncurie – a portmanteau derived from oncology and Mme. Curie, the discoverer of radioactivity – reflects our sharp focus on creating the technology to deliver radionuclides selectively to metastatic tissues. The vision of Oncurie is a world where treatments for metastatic cancer are selective, mild, and curative, enabling patients to live a normal cancer-free life.
“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.”
— Marie Curie
